James Wilmott

31PUBLICATIONS
247CO-AUTHORS
Molecular targetsPredictive and prognostic markersGenomics and transcriptomicsMedical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Jun 30, 2025
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors.

Ismael A Vergara, Nigel G Maher, Alison J Potter

|Nov 07, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Kathleen Conway, Sharon N Edmiston, Amanda Vondras

|Oct 07, 2024
Tissue-Based Profiling Techniques to Achieve Precision Medicine in Cancer: Opportunities and Challenges in Melanoma.

Tuba N Gide, Yizhe Mao, Richard A Scolyer

Pageof 6